Neutropenia Secondary to SARS-Cov2 Vaccination in Post-Hematopoietic Stem Cell Transplant (HSCT) Patients

SARS-Cov2 s, caused a high mortality in patients with some degree of immunosuppression, like those that receive a hematopoietic progenitor transplant. Since December 2020, several vaccines have been developed having been key in decreasing complications and mortality in this group of patients. Differ...

Full description

Saved in:

Bibliographic Details
Published in:	Mediterranean journal of hematology and infectious diseases Vol. 15; no. 1; p. e2023014
Main Authors:	Juárez-Salcedo, L M, Feijóo Monroy, S, García-Herce, C, Alonso, A, Aguado, B, Ortiz, J, Figuera, A, Cámara, J R
Format:	Journal Article
Language:	English
Published:	Italy Università Cattolica del Sacro Cuore 2023 Mattioli1885
Subjects:	anti SARS-CoV-2 vaccine bone marrow transplantation Letter to the Editor Neutropenia SARS-Cov2 Vaccination Neutropenia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	SARS-Cov2 s, caused a high mortality in patients with some degree of immunosuppression, like those that receive a hematopoietic progenitor transplant. Since December 2020, several vaccines have been developed having been key in decreasing complications and mortality in this group of patients. Different articles have described the presence of thrombopenia related to the administration of vaccines, however, there are few data on the occurrence of neutropenia as a side effect after administration. We present several cases of neutropenia (defined as absolute neutrophil count (ANC) less than 2,000/mm3), after vaccination in hematopoietic progenitor transplant (HPT) recipients performed in our center during 2021.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both author equally contributed to the article.
ISSN:	2035-3006 2035-3006
DOI:	10.4084/mjhid.2023.014